Home / Letter From The Editor / Dec. 17, 2019

Dec. 17, 2019

Dec 16, 2019
 

The FDA gave approval to Tandem’s Control IQ this past week and the word is on the streets already. My wife was at the endo office today and he was telling her about it, and told her it would improve her 6.1 A1c. He also mentioned that he may have to move from his Medtronic to the Dexcom/Tandem combination.

LILLY jumped back in the diabetes management arena as today they announced a collaboration with Dexcom to deliver information to the phone to be used with their new disposable pens that communicate. Interestingly enough they also announced that they were going to develop an insulin pump as well. Hmmm, have I heard that before?

 

 

 

Dave Joffe

Editor-in-chief